CHIMENTI, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 47.685
AS - Asia 6.386
EU - Europa 5.756
SA - Sud America 791
AF - Africa 154
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 23
Totale 60.848
Nazione #
US - Stati Uniti d'America 47.419
SG - Singapore 2.648
CN - Cina 1.609
DE - Germania 839
UA - Ucraina 779
RU - Federazione Russa 717
IT - Italia 706
BR - Brasile 678
HK - Hong Kong 528
FR - Francia 481
IE - Irlanda 479
VN - Vietnam 473
SE - Svezia 438
GB - Regno Unito 403
FI - Finlandia 272
PL - Polonia 194
CA - Canada 185
KR - Corea 185
IN - India 160
JP - Giappone 152
BD - Bangladesh 122
TR - Turchia 79
NL - Olanda 76
ES - Italia 69
PK - Pakistan 58
ID - Indonesia 55
BE - Belgio 52
AU - Australia 48
AR - Argentina 46
EG - Egitto 44
CH - Svizzera 42
MX - Messico 42
ZA - Sudafrica 35
IQ - Iraq 32
RO - Romania 30
IR - Iran 29
TW - Taiwan 29
UZ - Uzbekistan 28
PH - Filippine 26
AT - Austria 23
KG - Kirghizistan 23
MY - Malesia 21
GR - Grecia 20
EU - Europa 19
IL - Israele 19
AE - Emirati Arabi Uniti 17
EC - Ecuador 17
HU - Ungheria 17
LT - Lituania 17
CZ - Repubblica Ceca 16
MA - Marocco 16
PT - Portogallo 16
SK - Slovacchia (Repubblica Slovacca) 16
TH - Thailandia 15
CL - Cile 13
NG - Nigeria 12
CO - Colombia 11
OM - Oman 11
EE - Estonia 10
JM - Giamaica 10
KZ - Kazakistan 10
SA - Arabia Saudita 10
DZ - Algeria 9
JO - Giordania 9
NP - Nepal 9
PY - Paraguay 9
RS - Serbia 9
TN - Tunisia 9
DK - Danimarca 8
HR - Croazia 8
PE - Perù 8
ET - Etiopia 7
LB - Libano 6
LV - Lettonia 6
VE - Venezuela 6
CY - Cipro 5
NO - Norvegia 5
AZ - Azerbaigian 4
BJ - Benin 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KE - Kenya 4
NZ - Nuova Zelanda 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
GH - Ghana 3
HN - Honduras 3
KW - Kuwait 3
MD - Moldavia 3
NI - Nicaragua 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
GA - Gabon 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A1 - Anonimo 1
AD - Andorra 1
Totale 60.825
Città #
Woodbridge 13.772
Wilmington 10.827
Houston 9.447
Fairfield 1.589
Singapore 1.316
Ann Arbor 1.272
Chandler 1.064
Ashburn 1.042
Jacksonville 684
Seattle 671
San Jose 630
Beijing 566
Cambridge 561
Hong Kong 493
Dublin 476
Medford 384
New York 318
Dearborn 290
Zhengzhou 264
The Dalles 241
Santa Clara 226
Lawrence 181
Los Angeles 181
Council Bluffs 154
Dallas 141
Rome 141
Kraków 137
Hanoi 134
Tokyo 122
Ho Chi Minh City 116
Helsinki 103
Moscow 102
San Diego 98
Buffalo 96
Lauterbourg 89
Mülheim 87
Menlo Park 85
Shanghai 85
Munich 83
Boardman 76
São Paulo 72
Redwood City 62
Milan 54
London 49
Chicago 45
Toronto 44
Redondo Beach 42
Stockholm 41
Brooklyn 40
Warsaw 40
Hefei 39
Nanjing 39
San Mateo 39
Guangzhou 38
Montreal 37
Phoenix 36
Orem 35
Norwalk 33
Brussels 29
Denver 29
Jakarta 29
Frankfurt am Main 28
Jönköping 28
University Park 28
Ankara 27
Atlanta 25
Columbus 25
Verona 25
Falls Church 24
Madrid 24
Nuremberg 24
San Francisco 23
Chennai 21
Hangzhou 21
Kunming 21
Da Nang 20
Detroit 20
Haiphong 20
Mountain View 20
Naples 20
Palo Alto 20
Turin 20
Nanchang 19
Philadelphia 19
Belo Horizonte 18
Dong Ket 18
Auburn Hills 17
Boston 17
Johannesburg 17
Curitiba 16
Manchester 16
Poplar 16
Lahore 15
Rio de Janeiro 15
Duncan 14
Florence 14
Hamilton 14
Paris 14
Amsterdam 13
Baghdad 13
Totale 49.985
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.662
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.225
Quality of life in patients with plaque psoriasis treated with biologic therapies 815
Atopic dermatitis and dental manifestations 543
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 541
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 532
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 509
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 502
Topical lactoferrin can improve stable psoriatic plaque 501
Clinical aspects of the oral cavity in patients with psoriasis: an initial study and a proposal of a new evaluation method 500
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 500
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 498
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 490
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes 490
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 489
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 486
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 484
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 483
Apremilast for the treatment of psoriasis. 477
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 475
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 472
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 468
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 465
Tazarotene as alternative topical treatment for onychomycosis 462
Actinic keratosis treated with an immune response modifier: a case report of six patients 460
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 460
New topical treatments for psoriasis 459
Treatment of trachyonychia with tazarotene 457
Psoriasis, kaposi's sarcoma and hodgkin's disease in a patient with down's syndrome [2] 456
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 454
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 451
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 450
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 448
Lung nodule and facial erythematous plaques: a quiz 445
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 441
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 440
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 440
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 438
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 438
Stress reactivity in psoriatic patients 437
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 436
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 434
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 434
The significance of the development of antinuclear antibodies during infliximab treatment 433
Phrynoderma: a cutaneous sign of an inadequate diet 433
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 432
Reply to Scalone and Cortesi: ‘‘Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs’’ 432
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 432
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome 428
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice 428
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 427
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 426
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 426
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 423
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 422
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 422
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 421
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21 420
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 420
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 419
Severe acne successfully treated with etanercept 419
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus 419
Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study 419
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 419
Treatment of lentigo maligna with tazarotene 0.1% gel 418
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 417
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 414
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 413
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 411
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 410
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 407
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 405
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 405
Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy 403
Erysipeloid cutaneous metastasis from bladder carcinoma 402
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 402
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 399
Tofacitinib for the treatment of psoriasis 399
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 398
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 397
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 395
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 395
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 394
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 391
Pyoderma vegetans and ulcerative colitis 386
Analysis of risk factors in cutaneous malignant melanoma: an italian population-based study 386
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 386
Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene J Invest Dermatol. 2007 Sep;127(9):2271-3. 385
Zosteriform metastasis of occult bronchogenic carcinoma 381
Immunologic biomarkers for clinical and therapeutic management of psoriasis 381
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 380
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 380
HIV-associated primary cutaneous anaplastic large cell lymphoma: A clinicopathological subset with more aggressive behavior? Case report and review of the literature 378
Ichthyosiform mycosis fungoides: A neoplastic acquired ichthyosis [5] 377
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 377
Metastatic Crohn's disease of the forehead 371
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 371
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 370
From patients’ needs to treatment outcomes in psoriasis: Results from the ‘pSORRIDI’ experience 370
Graham Little-Piccardi-Lassueur syndrome: effective treatment with cyclosporin A 369
Totale 45.590
Categoria #
all - tutte 144.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 0 154
2021/20222.139 85 272 151 138 59 177 102 113 146 184 141 571
2022/20232.770 258 230 141 407 234 582 181 155 286 27 168 101
2023/20241.153 119 52 81 50 104 290 81 106 23 38 25 184
2024/20254.209 176 802 431 261 112 240 380 210 348 327 476 446
2025/20266.982 560 328 807 602 566 230 843 676 734 643 777 216
Totale 61.643